Bell Graeme 4
4 · Intellia Therapeutics, Inc. · Filed Jan 29, 2018
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-25+25,000→ 25,000 totalExercise: $22.78Exp: 2028-01-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 25, 2018 with respect to 25,000 shares of Common Stock, with 25% vesting on January 25, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.